VF
TNYA icon

Virtu Financial’s Tenaya Therapeutics TNYA Stock Holding History

Virtu Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,725
Closed -$23K – 2308
2025
Q4 		$23K Sell
32,725
-11,524
-26% -$15.7K ﹤0.01% 1405
2025
Q3 		$72K Sell
44,249
-125,245
-74% -$126K ﹤0.01% 1086
2025
Q2 		$104K Buy
169,494
+33,992
+25% +$17.3K 0.01% 1037
2025
Q1 		$77K Buy
135,502
+30,790
+29% +$30.4K ﹤0.01% 959
2024
Q4 		$150K Buy
+104,712
New +$235K 0.01% 949
2024
Q3 		– Sell
-13,720
Closed -$43K – 1887
2024
Q2 		$43K Buy
+13,720
New +$56.7K ﹤0.01% 926

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's TNYA Position: Q1 2026 in Review

Virtu Financial sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 32,725 shares — an estimated $23K sold.

Virtu Financial first reported a position in TNYA in Q2 2024 and held it in 6 quarters. The position peaked at $150K in Q4 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Virtu Financial reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 32,725 Tenaya Therapeutics shares in Q1 2026, an estimated $23K.
  • Virtu Financial first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 6 quarters.
  • Virtu Financial's Tenaya Therapeutics position peaked at $150K in Q4 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.